Search Orphan Drug Designations and Approvals
-
Generic Name: | Atrasentan |
---|---|
Date Designated: | 09/29/2016 |
Orphan Designation: | Treatment of pediatric nephrotic syndrome |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 10/01/2018 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AbbVie Inc. Regulatory Affairs 1 North Waukegan Road North Chicago, Illinois 60044 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-